HopeStage
Back to all studies
CompletedNCT00056472

Olanzapine and sertraline for depression with psychotic symptoms

About this titleRead the official source — NCT00056472
Medication studyAges 18+United States + Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Worcester and 3 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2003
Recruitment status
Completed
Enrollment listed in the registry
259
Sponsor
Weill Medical College of Cornell University
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Canada
Age range
Over 18 Years
Official registry ID
NCT00056472
Official title
Show the full official title

Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Worcester, United States · New York, United States · Pittsburgh, United States

1 more locations
  • Toronto, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Weill Medical College of Cornell University, a university.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine and Sertraline.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies